<DOC>
	<DOCNO>NCT00464490</DOCNO>
	<brief_summary>Mechanical ventilation commonly associate patient agitation require sedation alleviate discomfort reduce excessive central respiratory drive . Upon recovery acute respiratory failure , sedation reduce facilitate withdrawal ventilatory support . In patient , abrupt reduction sedation provokes severe agitation cause catecholamine release result severe hypertension , tachycardia tachypnea . This require increased sedation bring hemodynamic respiratory function control . Dexmedetomidine alpha-2 receptor agonist sedative analgesic property allow reduction anesthetic analgesic requirement perioperative setting . In addition sedative effect , alpha-2 receptor stimulation central nervous system inhibit sympathetic activity reduces plasma epinephrine norepinephrine level , thereby lower arterial blood pressure heart rate . Because alpha-2 receptor stimulation cause respiratory depression , dexmedetomidine may facilitate transition unassisted breathing profoundly agitate patient . The investigator prospectively evaluate dexmedetomidine 30 patient could extubated agitation hemodynamic instability tachypnea . The purpose study test large prospective randomize control pilot study show dexmedetomidine facilitates wean extubation patient fail previous attempt agitation hyperdynamic cardiopulmonary response .</brief_summary>
	<brief_title>Use Dexmedetomidine Facilitate Extubation Surgical ICU Patients Who Failed Previous Weaning Attempts</brief_title>
	<detailed_description>Sixty patient admitted surgical intensive care unit ( ICU ) San Francisco General Hospital refer investigator enrollment prospective , unblinded , randomize study dexmedetomidine . Each patient consider critical care team suitable candidate wean extubation base inclusion/ exclusion criterion . Pregnant patient enrol determined negative urine serum pregnancy test admission . If none available pregnancy test perform prior enrollment . Patients consider difficult wean base follow criterion : Eligible patient randomize either control arm dexmedetomidine arm 1:1 ratio use seal envelope . Patient randomize control arm extubated per standard hospital protocol . This arm study observational patient extubated attend physician patient whenever hemodynamically stable enough tolerate another wean trial . The study team collect data point control arm dexmedetomidine arm . This include ABGs , heart rate , mean blood pressure , respiratory rate RASS score ( see description data point collection time point . ) Arterial blood gas draw control arm study . Patients dexmedetomidine arm start dexmedetomidine either 0.5 mcg/kg/hr 0.7 mcg/kg/hr 1 hour prior extubation . The drug calculation base upon average take patient 's measure predict body weight . Background sedation generally facilitate lorazepam , midazolam propofol , analgesia maintain either fentanyl hydromorphine . After start dexmedetomidine background sedation analgesia titrate discontinue possible . Analgesia level also reduce tolerate . Dexmedetomidine titrate accord blood pressure , RASS heart rate response dose lower sedation discontinue markedly reduce . Aerosolized lidocaine ( 20 mg ) therapy initiate prior wean trial prevent excessive coughing patient . Shortly dexmedetomidine infusion start , PSV commence 5 cm H2O 5 cm H2O continuous positive airway pressure ( CPAP ) . Patients wean CPAP evaluate extubation . 1 . ) Arterial blood gas obtain patient arterial line three point time : prior dexmedetomidine infusion , CPAP trial , approximately 30 minute extubation . 3 . ) Heart rate , mean blood pressure , RASS , respiratory rate collect fifteen minute interval 1 hour prior dexmedetomidine infusion , 1 hour infusion dexmedetomidine prior extubation 5 , 15 , 30 , 45 , 60 , 90 120 minute extubation total 4 hour data collection .</detailed_description>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Age le 70 year old 2 . Normothermia ( 36.5 degree centigrade ) 3 . Normal sinus rhythm 4 . Hemodynamically stable ( systolic blood pressure [ SBP ] &gt; 110 mmHg ) 5 . Ejection fraction ( EF ) &gt; 40 % /absence congestive heart failure ( CHF ) 6 . Cardiac index &gt; 2.5 L/min/m2 7 . Minimal inotropic support ( &lt; 3 mcg/kg/min dobutamine ) 8 . Adequate coagulation profile 9 . Adequate urine output ( &gt; 100 ml/hr ) 10 . Primary service critical care physician agreement 1 . Prior use clonidine alphaantagonists 2 . Prior history intravenous drug abuse ( IVDA ) alcohol abuse ( ETOH ) 3 . Evidence heart block 4 . Difficulty oxygenation/ventilation 5 . Renal hepatic insufficiency 6 . Pregnant ( positive urine serum pregnancy test upon admission ) 7 . Patient receive dexmedetomidine &gt; 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Weaning</keyword>
	<keyword>Extuvation</keyword>
	<keyword>Dexmedetomidine</keyword>
</DOC>